Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 11;5(6):e503.
doi: 10.1212/NXI.0000000000000503. eCollection 2018 Nov.

MOG antibodies in combined central and peripheral demyelination syndromes

Rocio Vazquez Do Campo  1 , Alana Stephens  1 , I Vanessa Marin Collazo  1 , Devon I Rubin  1
Affiliations

MOG antibodies in combined central and peripheral demyelination syndromes

Rocio Vazquez Do Campo et al. Neurol Neuroimmunol Neuroinflamm. .
No abstract available

PubMed Disclaimer

Figures

Figure
Figure. Neuroimaging studies and sural nerve biopsy in CCPD associated with MOG-IgG1 antibodies
(A) Gadolinium-enhanced axial T1-weighted MRI of the brain, showing several enhancing lesions in the right pons/middle cerebellar peduncle (trigeminal nerve entry zone), (C) the left periatral region and subcortical white matter of both cerebral hemispheres; and (B and D) at 3-month follow-up, showing resolution of the previously observed contrast-enhancing supratentorial and infratentorial lesions. (E and G) Sagittal T2 short tau inversion recovery sequence MRI of the cervical and thoracic spine, showing a longitudinally extensive lesion from C5 through T1, lesions involving T10-T11 segments, and conus medullaris; and (F and H) at 3-month follow-up, showing a marked decrease in the size of previously observed cervical, thoracic, and conus medullaris lesions. (I) Teased nerve fiber preparation (×16) of the left sural nerve, revealing increased demyelination and remyelination (arrows) and axonal degeneration (asterisks). (J) Semithin epoxy-embedded section (×40), showing moderately to severely reduced myelinated fiber density and rare degenerating profiles (arrow). (K) CD45 (leukocyte common antigen) preparation (×16), showing reactive individual cells within the endoneurium (arrow) and a single small perivascular epineurial collection (not shown).
See this image and copyright information in PMC

References

    1. Ogata H, Matsuse D, Yamasaki R, et al. . A nationwide survey of combined central and peripheral demyelination in Japan. J Neurol Neurosurg Psychiatry 2016;87:29–36. - PubMed
    1. Cortese A, Franciotta D, Alfonsi E, et al. . Combined central and peripheral demyelination: clinical features, diagnostic findings, and treatment. J Neurol Sci 2016;15:182–187. - PubMed
    1. Wang Y, Chen H, Zhuang W, Li H. The clinical features of combined central and peripheral demyelination in Chinese patients. J Neuroimmunol 2018;15:32–36. - PubMed
    1. Tajima Y, Matsumura M, Yaguchi H, Mito Y. Possible combined central and peripheral demyelination presenting as optic neuritis, cervical myelitis, and demyelinating polyneuropathy with marked nerve hypertrophy. Intern Med 2018;57:867–871. - PMC - PubMed
    1. Jarius S, Paul F, Aktas O, et al. . MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 2018;15:134. - PMC - PubMed

LinkOut - more resources